Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SR Splicing Factors Promote Cancer via Multiple Regulatory Mechanisms. | Genes (Basel) | 2022 | 36140826 | PubTator, text mining | PubMed |
| Causes and Pathophysiology of Acquired Sideroblastic Anemia. | Genes (Basel) | 2022 | 36140729 | PubTator, text mining | PubMed |
| Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection. | Cancers (Basel) | 2022 | 36139664 | PubTator, text mining | PubMed |
| Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients. | Cancers (Basel) | 2022 | 36139644 | PubTator, text mining | PubMed |
| Molecular Characterizations of Gynecologic Carcinosarcomas: A Focus on the Immune Microenvironment. | Cancers (Basel) | 2022 | 36139624 | PubTator, text mining | PubMed |
| The Biological and Clinical Consequences of RNA Splicing Factor U2AF1 Mutation in Myeloid Malignancies. | Cancers (Basel) | 2022 | 36139566 | PubTator, text mining | PubMed |
| High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance. | Nat Commun | 2022 | 36138008 | PubTator, text mining | PubMed |
| Tumor Mutational Burden by Whole-Genome Sequencing in Resected NSCLC of Never Smokers. | Cancer Epidemiol Biomarkers Prev | 2022 | 36126278 | PubTator, text mining | PubMed |
| CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway. | Cell Death Dis | 2022 | 36123327 | PubTator, text mining | PubMed |
| Unique role of DDX41, a DEAD-box type RNA helicase, in hematopoiesis and leukemogenesis. | Front Oncol | 2022 | 36119490 | PubTator, text mining | PubMed |
| The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis. | Front Oncol | 2022 | 36119476 | PubTator, text mining | PubMed |
| Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies. | Mediterr J Hematol Infect Dis | 2022 | 36119457 | PubTator, text mining | PubMed |
| Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation. | Semin Hematol | 2022 | 36115690 | PubTator, text mining | PubMed |
| ALS-linked loss of Cyclin-F function affects HSP90. | Life Sci Alliance | 2022 | 36114006 | PubTator, text mining | PubMed |
| Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients. | Am J Hematol | 2022 | 36109871 | PubTator, text mining | PubMed |
| Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor. | Pediatr Surg Int | 2022 | 36107237 | PubTator, text mining | PubMed |
| Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure. | Cancers (Basel) | 2022 | 36077850 | PubTator, text mining | PubMed |
| Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells. | Cancers (Basel) | 2022 | 36077669 | PubTator, text mining | PubMed |
| Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes. | Cancers (Basel) | 2022 | 36077644 | PubTator, text mining | PubMed |
| A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML. | Leuk Lymphoma | 2022 | 36075047 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=41